Publications in collaboration with researchers from Tel Aviv University (9)

2026

  1. Defective RNA Polymerase III sensing of mitochondrial DNA in pulmonary epithelial cells impairs type I IFN immunity to SARS-CoV-2

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 123, Núm. 12

2025

  1. A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity

    Journal of Experimental Medicine, Vol. 222, Núm. 2

  2. Deleterious variants in the autophagy-related gene RB1CC1/FIP200 impair immunity to SARS-CoV-2

    Nature Communications , Vol. 16, Núm. 1

2024

  1. Erratum: Correction: Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 (Genome medicine (2023) 15 1 (22))

    Genome medicine

2023

  1. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

    Nature, Vol. 623, Núm. 7988, pp. 803-813

  2. Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia

    Journal of Experimental Medicine, Vol. 220, Núm. 5

  3. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

    Genome Medicine, Vol. 15, Núm. 1

2022

  1. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection

    Nature Immunology, Vol. 23, Núm. 2, pp. 159-164

  2. Decoding the Human Genetic and Immunological Basis of COVID-19 mRNA Vaccine-Induced Myocarditis

    Journal of Clinical Immunology